Autoinjectors Market (Type: Disposable and Reusable; Technology: Handheld and Wearable; Indication: Multiple Sclerosis, Rheumatoid Arthritis, Diabetes, Anaphylaxis, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-20

Autoinjectors Market (Type: Disposable and Reusable; Technology: Handheld and Wearable; Indication: Multiple Sclerosis, Rheumatoid Arthritis, Diabetes, Anaphylaxis, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031


Autoinjectors Market – Scope of Report


TMR’s report on the global Autoinjectors Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Autoinjectors Market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Autoinjectors Market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the Autoinjectors Market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Autoinjectors Market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Autoinjectors Market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Autoinjectors Market.

The report delves into the competitive landscape of the global Autoinjectors Market. Key players operating in the global Autoinjectors Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Autoinjectors Market profiled in this report.

Key Questions Answered in Global Autoinjectors Market Report
  • What is the sales/revenue generated by mobile photo printer across all regions during the forecast period?
  • What are the opportunities in the global Autoinjectors Market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?
Autoinjectors Market – Research Objectives and Research Approach

The comprehensive report on the global Autoinjectors Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Autoinjectors Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Autoinjectors.


1. Preface
  1.1. Market Definition and Scope
  1.2. Market Segmentation
  1.3. Key Research Objectives
  1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Autoinjectors Market
4. Market Overview
  4.1. Introduction
4.1.1. Segment Definition
  4.2. Overview
  4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
  4.4. Global Autoinjectors Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
  5.1. Technological Advancement
  5.2. Disease Incidence and Prevalence
  5.3. Overview: Future of Autoinjectors
  5.4. Regulatory Analysis
  5.5. COVID-19 Impact Analysis
6. Global Autoinjectors Market Analysis and Forecast, by Type
  6.1. Introduction & Definition
  6.2. Key Findings / Developments
  6.3. Market Value Forecast, by Type, 2017-2031
6.3.1. Disposable
6.3.2. Reusable
  6.4. Market Attractiveness Analysis, by Type
7. Global Autoinjectors Market Analysis and Forecast, by Technology
  7.1. Introduction & Definition
  7.2. Key Findings / Developments
  7.3. Market Value Forecast, by Technology, 2017-2031
7.3.1. Handheld
7.3.2. Wearable
  7.4. Market Attractiveness Analysis, by Technology
8. Global Autoinjectors Market Analysis and Forecast, by Route of Administration
  8.1. Introduction & Definition
  8.2. Key Findings / Developments
  8.3. Market Value Forecast, by Route of Administration, 2017-2031
8.3.1. Subcutaneous
8.3.2. Intramuscular
  8.4. Market Attractiveness Analysis, by Route of Administration
9. Global Autoinjectors Market Analysis and Forecast, by Indication
  9.1. Introduction & Definition
  9.2. Key Findings / Developments
  9.3. Market Value Forecast, by Indication, 2017-2031
9.3.1. Multiple Sclerosis
9.3.2. Rheumatoid Arthritis
9.3.3. Diabetes
9.3.4. Anaphylaxsis
9.3.5. Others
  9.4. Market Attractiveness Analysis, by Indication
10. Global Autoinjectors Market Analysis and Forecast, by End-user
  10.1. Introduction & Definition
  10.2. Key Findings / Developments
  10.3. Market Value Forecast, by End-user, 2017-2031
10.3.1. Homecare Settings
10.3.2. Hospitals & Clinics
  10.4. Market Attractiveness Analysis, by End-user
11. Global Autoinjectors Market Analysis and Forecast, by Region
  11.1. Key Findings
  11.2. Market Value Forecast, by Region
11.2.1. North America
11.2.2. Europe
11.2.3. Asia Pacific
11.2.4. Latin America
11.2.5. Middle East & Africa
  11.3. Market Attractiveness Analysis, by Region
12. North America Autoinjectors Market Analysis and Forecast
  12.1. Introduction
12.1.1. Key Findings
  12.2. Market Value Forecast, by Type, 2017-2031
12.2.1. Disposable
12.2.2. Reusable
  12.3. Market Value Forecast, by Technology, 2017-2031
12.3.1. Handheld
12.3.2. Wearable
  12.4. Market Value Forecast, by Route of Administration, 2017-2031
12.4.1. Subcutaneous
12.4.2. Intramuscular
  12.5. Market Value Forecast, by Indication, 2017-2031
12.5.1. Multiple Sclerosis
12.5.2. Rheumatoid Arthritis
12.5.3. Diabetes
12.5.4. Anaphylaxsis
12.5.5. Others
  12.6. Market Value Forecast, by End-user, 2017-2031
12.6.1. Homecare Settings
12.6.2. Hospitals & Clinics
  12.7. Market Value Forecast, by Country, 2017-2031
12.7.1. U.S.
12.7.2. Canada
  12.8. Market Attractiveness Analysis
12.8.1. By Type
12.8.2. By Technology
12.8.3. By Route of Administration
12.8.4. By Indication
12.8.5. By End-user
12.8.6. By Country
13. Europe Autoinjectors Market Analysis and Forecast
  13.1. Introduction
13.1.1. Key Findings
  13.2. Market Value Forecast, by Type, 2017-2031
13.2.1. Disposable
13.2.2. Reusable
  13.3. Market Value Forecast, by Technology, 2017-2031
13.3.1. Handheld
13.3.2. Wearable
  13.4. Market Value Forecast, by Route of Administration, 2017-2031
13.4.1. Subcutaneous
13.4.2. Intramuscular
  13.5. Market Value Forecast, by Indication, 2017-2031
13.5.1. Multiple Sclerosis
13.5.2. Rheumatoid Arthritis
13.5.3. Diabetes
13.5.4. Anaphylaxsis
13.5.5. Others
  13.6. Market Value Forecast, by End-user, 2017-2031
13.6.1. Homecare Settings
13.6.2. Hospitals & Clinics
  13.7. Market Value Forecast, by Country/Sub-region, 2017-2031
13.7.1. Germany
13.7.2. U.K.
13.7.3. France
13.7.4. Italy
13.7.5. Spain
13.7.6. Rest of Europe
  13.8. Market Attractiveness Analysis
13.8.1. By Type
13.8.2. By Technology
13.8.3. By Route of Administration
13.8.4. By Indication
13.8.5. By End-user
13.8.6. By Country/Sub-region
14. Asia Pacific Autoinjectors Market Analysis and Forecast
  14.1. Introduction
14.1.1. Key Findings
  14.2. Market Value Forecast, by Type, 2017-2031
14.2.1. Disposable
14.2.2. Reusable
  14.3. Market Value Forecast, by Technology, 2017-2031
14.3.1. Handheld
14.3.2. Wearable
  14.4. Market Value Forecast, by Route of Administration, 2017-2031
14.4.1. Subcutaneous
14.4.2. Intramuscular
  14.5. Market Value Forecast, by Indication, 2017-2031
14.5.1. Multiple Sclerosis
14.5.2. Rheumatoid Arthritis
14.5.3. Diabetes
14.5.4. Anaphylaxsis
14.5.5. Others
  14.6. Market Value Forecast, by End-user, 2017-2031
14.6.1. Homecare Settings
14.6.2. Hospitals & Clinics
  14.7. Market Value Forecast, by Country/Sub-region, 2017-2031
14.7.1. China
14.7.2. Japan
14.7.3. India
14.7.4. Australia & New Zealand
14.7.5. Rest of Asia Pacific
  14.8. Market Attractiveness Analysis
14.8.1. By Type
14.8.2. By Route of Administration
14.8.3. By Technology
14.8.4. By Indication
14.8.5. By End-user
14.8.6. By Country/Sub-region
15. Latin America Autoinjectors Market Analysis and Forecast
  15.1. Introduction
15.1.1. Key Findings
  15.2. Market Value Forecast, by Type, 2017-2031
15.2.1. Disposable
15.2.2. Reusable
  15.3. Market Value Forecast, by Technology, 2017-2031
15.3.1. Handheld
15.3.2. Wearable
  15.4. Market Value Forecast, by Route of Administration, 2017-2031
15.4.1. Subcutaneous
15.4.2. Intramuscular
  15.5. Market Value Forecast, by Indication, 2017-2031
15.5.1. Multiple Sclerosis
15.5.2. Rheumatoid Arthritis
15.5.3. Diabetes
15.5.4. Anaphylaxsis
15.5.5. Others
  15.6. Market Value Forecast, by End-user, 2017-2031
15.6.1. Homecare Settings
15.6.2. Hospitals & Clinics
  15.7. Market Value Forecast, by Country/Sub-region, 2017-2031
15.7.1. Brazil
15.7.2. Mexico
15.7.3. Rest of Latin America
  15.8. Market Attractiveness Analysis
15.8.1. By Type
15.8.2. By Technology
15.8.3. By Route of Administration
15.8.4. By Indication
15.8.5. By End-user
15.8.6. By Country/Sub-region
16. Middle East & Africa Autoinjectors Market Analysis and Forecast
  16.1. Introduction
16.1.1. Key Findings
  16.2. Market Value Forecast, by Type, 2017-2031
16.2.1. Disposable
16.2.2. Reusable
  16.3. Market Value Forecast, by Technology, 2017-2031
16.3.1. Handheld
16.3.2. Wearable
  16.4. Market Value Forecast, by Route of Administration, 2017-2031
16.4.1. Subcutaneous
16.4.2. Intramuscular
  16.5. Market Value Forecast, by Indication, 2017-2031
16.5.1. Multiple Sclerosis
16.5.2. Rheumatoid Arthritis
16.5.3. Diabetes
16.5.4. Anaphylaxsis
16.5.5. Others
  16.6. Market Value Forecast, by End-user, 2017-2031
16.6.1. Homecare Settings
16.6.2. Hospitals & Clinics
  16.7. Market Value Forecast, by Country/Sub-region, 2017-2031
16.7.1. GCC Countries
16.7.2. South Africa
16.7.3. Rest of Middle East & Africa
  16.8. Market Attractiveness Analysis
16.8.1. By Type
16.8.2. By Technology
16.8.3. By Route of Administration
16.8.4. By Indication
16.8.5. By End-user
16.8.6. By Country/Sub-region
17. Competition Landscape
  17.1. Market Player - Competition Matrix (By Tier and Size of companies)
  17.2. Market Share Analysis By Company (2022)
  17.3. Company Profiles
17.3.1. Ypsomed Holding AG
17.3.1.1. Company Overview
17.3.1.2. Financial Overview
17.3.1.3. Product Portfolio
17.3.1.4. Business Strategies
17.3.1.5. Recent Developments
17.3.2. Novartis AG
17.3.2.1. Company Overview
17.3.2.2. Financial Overview
17.3.2.3. Product Portfolio
17.3.2.4. Business Strategies
17.3.2.4. Recent Developments
17.3.3. BD
17.3.3.1. Company Overview
17.3.3.2. Financial Overview
17.3.3.3. Product Portfolio
17.3.3.4. Business Strategies
17.3.3.5. Recent Developments
17.3.4. Medmix Healthcare
17.3.4.1. Company Overview
17.3.4.2. Financial Overview
17.3.4.3. Product Portfolio
17.3.4.4. Business Strategies
17.3.4.5. Recent Developments
17.3.5. Eli Lilly and Company
17.3.5.1. Company Overview
17.3.5.2. Financial Overview
17.3.5.3. Product Portfolio
17.3.5.4. Business Strategies
17.3.5.5. Recent Developments
17.3.6. Sanofi
17.3.6.1. Company Overview
17.3.6.2. Financial Overview
17.3.6.3. Product Portfolio
17.3.6.4. Business Strategies
17.3.6.5. Recent Developments
17.3.7. Mylan N.V.
17.3.7.1. Company Overview
17.3.7.2. Financial Overview
17.3.7.3. Product Portfolio
17.3.7.4. Business Strategies
17.3.7.5. Recent Developments
17.3.8. Amgen Inc.
17.3.8.1. Company Overview
17.3.8.2. Financial Overview
17.3.8.3. Product Portfolio
17.3.8.4. Business Strategies
17.3.8.5. Recent Developments
17.3.9. SHL Medical AG
17.3.9.1. Company Overview
17.3.9.2. Financial Overview
17.3.9.3. Product Portfolio
17.3.9.4. Business Strategies
17.3.9.5. Recent Developments
17.3.10. Recipharm AB
17.3.10.1. Company Overview
17.3.10.2. Financial Overview
17.3.10.3. Product Portfolio
17.3.10.4. Business Strategies
17.3.10.5. Recent Developments

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings